Literature DB >> 29360535

Microbial biotransformation of bioactive and clinically useful steroids and some salient features of steroids and biotransformation.

Nighat Sultana1.   

Abstract

Steroids are perhaps one of the most widely used group of drugs in present day. Beside the established utilization as immunosuppressive, anti-inflammatory, anti-rheumatic, progestational, diuretic, sedative, anabolic and contraceptive agents, recent applications of steroid compounds include the treatment of some forms of cancer, osteoporosis, HIV infections and treatment of declared AIDS. Steroids isolated are often available in minute amounts. So biotransformation of natural products provides a powerful means in solving supply problems in clinical trials and marketing of the drug for obtaining natural products in bulk amounts. If the structure is complex, it is often an impossible task to isolate enough of the natural products for clinical trials. The microbial biotransformation of steroids yielded several novel metabolites, exhibiting different activities. The metabolites produced from pregnenolone acetate by Cunning hamella elegans and Rhizopus stolonifer were screened against tyrosinase and cholinesterase showed significant inhibitory activities than the parent compound. Diosgenin and its transformed sarsasapogenin were screened for their acetyl cholinesterase and butyryl cholinesterase inhibitory activities. Sarsasapogenin was screened for phytotoxicity, and was found to be more active than the parent compound. Diosgenin, prednisone and their derivatives were screened for their anti-leishmanial activity. All derivatives were found to be more active than the parent compound. The biotransformation of steroids have been reviewed to a little extent. This review focuses on the biotransformation and functions of selected steroids, the classification, advantages and agents of enzymatic biotransformation and examines the potential role of new enzymatically transformed steroids and their derivatives in the chemoprevention and treatment of other diseases. tyrosinase and cholinesterase inhibitory activities, severe asthma, rheumatic disorders, renal disorders and diseases of inflammatory bowel, skin, gastrointestinal tract.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioactive cyclic compounds; Biological significance; Biotransformation; Biotransformation advantages; Biotransformation agents; Derivatives; Enzymes; Steroid

Mesh:

Substances:

Year:  2018        PMID: 29360535     DOI: 10.1016/j.steroids.2018.01.007

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  6 in total

1.  Betamethasone Dipropionate Derivatization, Biotransformation, Molecular Docking, and ADME Analysis as Glucocorticoid Receptor.

Authors:  Sana Rashid; Shazia Anjum; Aqeel Ahmad; Raziya Nadeem; Maqsood Ahmed; Syed Adnan Ali Shah; Muhammad Abdullah; Komal Zia; Zaheer Ul-Haq
Journal:  Biomed Res Int       Date:  2022-07-06       Impact factor: 3.246

Review 2.  Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.

Authors:  Paul Awolade; Nosipho Cele; Nagaraju Kerru; Lalitha Gummidi; Ebenezer Oluwakemi; Parvesh Singh
Journal:  Eur J Med Chem       Date:  2019-12-04       Impact factor: 6.514

Review 3.  The Antitumor Activities of Marsdenia tenacissima.

Authors:  Xiang Wang; Yuanliang Yan; Xi Chen; Shuangshuang Zeng; Long Qian; Xinxin Ren; Jie Wei; Xue Yang; Yangying Zhou; Zhicheng Gong; Zhijie Xu
Journal:  Front Oncol       Date:  2018-10-23       Impact factor: 6.244

4.  Biotransformation of Cortisone with Rhodococcus rhodnii: Synthesis of New Steroids.

Authors:  Federico Zappaterra; Stefania Costa; Daniela Summa; Valerio Bertolasi; Bruno Semeraro; Paola Pedrini; Raissa Buzzi; Silvia Vertuani
Journal:  Molecules       Date:  2021-03-03       Impact factor: 4.411

5.  Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability.

Authors:  Pei Liu; Jian-Yu Zhou; Jin-Hua Chang; Xi-Gang Liu; He-Fei Xue; Ru-Xing Wang; Zhong-Si Li; Chun-Shi Li; Jian Wang; Cui-Zhe Liu
Journal:  Drug Des Devel Ther       Date:  2020-07-27       Impact factor: 4.162

6.  Whole-genome and enzymatic analyses of an androstenedione-producing Mycobacterium strain with residual phytosterol-degrading pathways.

Authors:  Hongwei Wang; Shikui Song; Fei Peng; Fei Yang; Tian Chen; Xin Li; Xiyao Cheng; Yijun He; Yongqi Huang; Zhengding Su
Journal:  Microb Cell Fact       Date:  2020-10-02       Impact factor: 5.328

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.